Topical β-Blockers Are Not Associated with an Increased Risk of Treatment for Depression

Ophthalmology

Volumn 113, Issue 7, 2006, Pages 1077-1080

  Kaiserman, Igor ^a   Kaiserman, Nadia ^b   Elhayany, Asher ^c   Vinker, Shlomo ^c,d  

^a BARZILAI MEDICAL CENTER   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c CLALIT HEALTH SERVICES   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; LEVOBUNOLOL; TIMOLOL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHI SQUARE TEST; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DRUG EFFECT; FEMALE; GLAUCOMA; HUMAN; ISRAEL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTCOME ASSESSMENT; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STRATIFICATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; ANTIHYPERTENSIVE AGENTS; CHRONIC DISEASE; DEPRESSION; FEMALE; GLAUCOMA, OPEN-ANGLE; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; ISRAEL; MALE; MIDDLE AGED; PRESCRIPTIONS, DRUG; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 33745390675     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2006.02.056     Document Type: Article

References (22)

1. Martinez G.S., Campbell A.J., Reinken J., and Allan B.C. Prevalence of ocular disease in a population study of subjects 65 years old and older. Am J Ophthalmol 94 (1982) 181-189
2. Gibson J.M., Rosenthal A.R., and Lavery J. A study of the prevalence of eye disease in the elderly in an English community. Trans Ophthalmol Soc U K 104 (1985) 196-203
3. Khaw P.T., Shah P., and Elkington A.R. Glaucoma-2. treatment. BMJ 328 (2004) 156-158
4. Frishman W.H., Fuksbrumer M.S., and Tannenbaum M. Topical ophthalmic beta-adrenergic blockade for the treatment of glaucoma and ocular hypertension. J Clin Pharmacol 34 (1994) 795-803
5. Brubaker R.F. Flow of aqueous humor in humans (the Friedenwald Lecture). Invest Ophthalmol Vis Sci 32 (1991) 3145-3166
6. Tan A.Y., LeVatte T.L., Archibald M.L., et al. Timolol concentrations in rat ocular tissues and plasma after topical and intraperitoneal dosing. J Glaucoma 11 (2002) 134-142
7. Leuppi J.D., Schnyder P., Hartmann K., et al. Drug-induced bronchospasm. analysis of 187 spontaneously reported cases. Respiration 68 (2001) 345-351
8. Vander Zanden J.A., Valuck R.J., Bunch C.L., et al. Systemic adverse effects of ophthalmic beta-blockers. Ann Pharmacother 35 (2001) 1633-1637
9. Lama P.J. Systemic adverse effects of beta-adrenergic blockers. an evidence-based assessment. Am J Ophthalmol 134 (2002) 749-760
10. Schweitzer I., Maguire K., and Tuckwell V. Antiglaucoma medication and clinical depression. Aust N Z J Psychiatry 35 (2001) 569-571
11. Cove-Smith J.R., and Kirk C.A. CNS-related side-effects with metoprolol and atenolol. Eur J Clin Pharmacol 28 suppl (1985) 69-72
12. Kessler R.C., McGonagle K.A., Zhao S., et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51 (1994) 8-19
13. Kimmel P.L., Thamer M., Richard C.M., and Ray N.F. Psychiatric illness in patients with end-stage renal disease. Am J Med 105 (1998) 214-221
14. Amato L., Paolisso G., Cacciatore F., et al., Osservatorio Geriatrico of Campania Region Group. Non-insulin-dependent diabetes mellitus is associated with a greater prevalence of depression in the elderly. Diabetes Metab 22 (1996) 314-318
15. Valvanne J., Juva K., Erkinjuntti T., and Tilvis R. Major depression in the elderly. a population study in Helsinki. Int Psychogeriatr 8 (1996) 437-443
16. Ko D.T., Hebert P.R., Coffey C.S., et al. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 288 (2002) 351-357
17. Patten S.B., and Lavorato D.H. Medication use and major depressive syndrome in a community population. Compr Psychiatry 42 (2001) 124-131
18. Ried L.D., McFarland B.H., Johnson R.E., and Brody K.K. Beta-blockers and depression. the more the murkier?. Ann Pharmacother 32 (1998) 699-708
19. Bright R.A., and Everitt D.E. Beta-blockers and depression. Evidence against an association. JAMA 267 (1992) 1783-1787
20. Wilson M.R., Coleman A.L., Yu F., et al. Depression in patients with glaucoma as measured by self-report surveys. Ophthalmology 109 (2002) 1018-1022
21. Duch S., Duch C., Pasto L., and Ferrer P. Changes in depressive status associated with topical beta-blockers. Int Ophthalmol 16 (1992) 331-335
22. Valuck R.J., Perlman J.I., Anderson C., and Wortman G.I. Co-prescribing of medications used to treat obstructive lung disease, congestive heart failure and depression among users of topical beta blockers. estimates from three US Veterans Affairs Medical Centers. Pharmacoepidemiol Drug Saf 10 (2001) 511-516